article thumbnail

University of Melbourne reveals design of new infectious disease institute

Pharmaceutical Technology

The new AIID building will include a human infection challenge unit, high-containment facilities, a robotic biobanking facility, interview rooms, dry laboratories and spaces for community engagement and co-design work. It will be located at 766–780 Elizabeth Street and 213–223 Berkely Street in the Melbourne biomedical precinct.

article thumbnail

Drug discovery hotspots: Focus on Qatar

Drug Discovery World

As such, Qatar Biobank has emerged within this modernisation to act as a focal point for the country’s goal in preventive and personalised healthcare. Qatar Biobank could be an essential partner in this. It also fits with the country’s preventative health approach that it established in its 2017-2022 Public Health Strategy 5.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why early participant engagement is now a top priority in genetic disease research

pharmaphorum

The DNA of these so-called ‘genetic superheroes’ may contain clues about how to treat severe disease. In our experience of running 20+ precision medicine studies, there are a few design principles that every research programme – from biobanks to clinical trials – should consider.

article thumbnail

Alnylam finds belly fat gene and drug target in UK Biobank study

pharmaphorum

The finding came from an analysis of sequencing data from more than 360,000 individuals in the UK Biobank , which contains genetic and health information from half a million UK participants. The post Alnylam finds belly fat gene and drug target in UK Biobank study appeared first on. Image by Bruno /Germany from Pixabay .

article thumbnail

New Research Reveals How Air Pollution May Trigger Lung Cancer

XTalks

In fact, one in every 600,000 cells in the lungs of a 50-year-old already contains potentially cancerous mutations. And although EGFR and KRAS mutations are commonly found in lung cancer not caused by smoking, they alone are not enough to trigger the cancer. The Double Hit. Results of the investigations showed that PM 2.5

article thumbnail

Biorepositories as a Guiding Resource for Research & Drug Discovery

XTalks

Biobanks are used for the coordination of high-yield patient sample collection. Moreover, biobanks are no longer passive biorepositories for accrual of samples and serve a more utilitarian function in identifying and coordinating specific research cohorts for longitudinal and prospective studies. Biobanking Models.

article thumbnail

WORLD’S LARGEST BROWSABLE RESOURCE LINKING RARE PROTEIN-CODING GENETIC VARIANTS TO HUMAN HEALTH AND DISEASE

The Pharma Data

Managed by the Broad Institute of MIT and Harvard, the browser gives access to results from analyses of whole exome sequencing data from 300,000 UK Biobank research participants. PFIZER DISCLOSURE NOTICE: The information contained in this release is as of July 8, 2021. (Nasdaq: BIIB) and Pfizer (NYSE: PFE). Biogen Safe Harbor.